11 November 2022 The Radiation Control Unit of the South African Health Products Regulatory Authority (SAHPRA) held a short and free webinar that intends to educate you on how to interpret the calibration certificates for radiation monitoring instruments. We have invited panellists from two sectors to share their knowledge, experience, and expertise to begin this...
Gqerberha, 21 October 2022 – The South African Health Products Regulatory Authority (SAHPRA), as part of its awareness campaign targeting tertiary institutions, visited the Eastern Cape’s Nelson Mandela University (NMU) on Friday, the 21st of October. Human Resources (HR) and the Office of the Chief...
Pretoria, 10 October 2022 – The South African Health Products Regulatory Authority (SAHPRA) hosted representatives from Germany’s Paul Ehrlich Institut’s (PEI) BloodTrain programme to discuss activities in strengthening blood and blood product regulations in Africa. SAHPRA enters this collaboration after participating in the PEI and African...
Pretoria, 10 October 2022 – The South African Health Products Regulatory Authority (SAHPRA), like other regulators globally, has been alerted to dubious health products being traded by an Indian company, Maiden Pharmaceuticals. The products as they appear on the World Health Organisation (WHO) product list (Medical...
Pretoria, 07 October 2022 – The South African Health Products Regulatory Authority (SAHPRA) hosted the African Union Development Agency (AUDA-NEPAD) as part of the African Union’s Smart Safety Surveillance (AU-3S) programme. African Union’s Smart Safety Surveillance (AU-3S) programme is aimed at strengthening the safety surveillance of...
Pretoria, 06 October 2022 – The South African Health Products Regulatory Authority (SAHPRA), as part of its awareness campaign targeting tertiary institutions, visited the University of the Witwatersrand (Wits) on Thursday, the 6th of October. Human Resources (HR) and the Inspectorate and Regulatory Compliance unit...
Pretoria, 5 October 2022 - The South African Health Products Regulatory Authority (SAHPRA) has recently been ranked by the World Health Organisation (WHO) at a functional level of maturity (Level 3) according to WHO’s global classification system for national medical products regulatory authorities. This means...
UPDATE ON COVID-19 HEALTH PRODUCTS: SAHPRA registers the Covovax COVID-19 vaccine from Cipla (Pty) Ltd and additional indication of use of COVID-19 vaccine MC Pharma from MC Pharma (Pty) Ltd in the age group 3 -17 years. Pretoria, 28 September 2022 – SAHPRA registered a COVID-19...
Patient safety resonates with SAHPRA’s mission of ensuring that the public is protected by registering and regulating all health products so that they comply with SAHPRA’s pillars of safety, quality, efficacy and performance. This involves ensuring that stringent regulatory requirements are followed before any health product is made...
Pretoria, 12 September 2022 - On the 04th of August 2022, SAHPRA issued a media statement relating to the first fatal case of GBS following vaccination with COVID-19 Vaccine Janssen. Recently, SAHPRA has been informed of a second fatal case of Guillain-Barré syndrome (GBS) following...
